---
$id: https://graph.org.ai/products/commodity/51451606
$type: Product
source: UNSPSC
code: "51451606"
title: "Triclabendazole"
class: "51451600"
classTitle: "Anthelmintic benzimidazoles"
family: "51450000"
familyTitle: "Anthelmintics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Triclabendazole

**UNSPSC Code**: 51451606
**Class**: [Anthelmintic benzimidazoles](Anthelmintic benzimidazoles.mdx)
**Family**: [Anthelmintics](../Anthelmintics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antihelminthic agent with the molecular formula C14H9Cl3N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4784C8E03O, chemically known as 6-chloro-5-(2,3-dichlorophenoxy)-2-methylthio-benzimidazole but generally known as triclabendazole, which bears US NIH Compound Identifier 50248. European Medicines Agency schedules Triclabendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11267MIG. The term TRICLABENDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules triclabendazole in its Anatomical Therapeutic Chemical (ATC) Classification. TRICLABENDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule triclabendazole under HS 29339990 and SITC 51577. As of Q4 2014, TRICLABENDAZOLE remains the US FDA Preferred Term for this commodity. Triclabendazole bears US NLM identifiers UMLS ID C0077071 and NCI Concept Code C75236. SMILES: CLC1C(OC2C(CL)C(CL)CCC2)CC2NC(SC)[NH]C2C1.

